Icu Medical Stock Price, News & Analysis

ICU Medical, Inc. (Nasdaq:ICUI) has announced that its management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare Conference on September 12, 2022, at 11:15 a.m. PT (2:15 p.m. ET). The event will be accessible via a live webcast on the company's website, with a replay available afterward. Additionally, one-on-one meetings will also be held on the same day. ICU Medical specializes in infusion systems and critical care products, serving various healthcare settings.

ICU Medical reported strong second quarter results for 2022, with revenues of $561 million, up from $321.7 million year-over-year. GAAP gross profit increased to $167.6 million, but gross margin fell to 30% from 38%. The company incurred a net loss of $7.5 million compared to a profit of $28.4 million in Q2 2021. Adjusted EBITDA rose to $84.7 million, although adjusted earnings per share decreased from $1.88 to $1.37. The company updated its 2022 guidance, lowering adjusted EBITDA expectations to $350-$370 million and adjusted earnings per share to $6.20-$6.80.

ICU Medical, Inc. (Nasdaq:ICUI) announced the timing of its second quarter 2022 earnings release and conference call. The earnings results will be disclosed on August 8, 2022, at approximately 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET. Stakeholders can access the call at (877) 300-8521, using conference ID 10169518. A webcast will also be available on the company's website. ICU Medical specializes in infusion systems and critical care products, catering to hospital and home care settings.

ICU Medical reported strong financial results for Q1 2022, with revenue reaching $543.1 million, up $225.1 million from $318.0 million in Q1 2021. GAAP gross profit stood at $168.8 million (31% gross margin) compared to $112.7 million (35% margin) the previous year. However, the company faced a GAAP net loss of $(38.1) million or $(1.61) per share, contrasting with net income of $23.7 million in Q1 2021. Adjusted diluted EPS improved to $1.82, while adjusted EBITDA rose to $84.9 million.

ICU Medical, Inc. (Nasdaq: ICUI) has scheduled its first quarter 2022 earnings release for May 9, 2022, at 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET. The call will be accessible by phone at (877) 407-3982 and will also be streamed live via the company's website. ICU Medical specializes in infusion systems and critical care products used in various healthcare settings. The company emphasizes its commitment to quality and innovation for clinical customers worldwide.

SAN CLEMENTE, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- ICU Medical, a leader in innovative medical products, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2022, at 8:15 a.m. PT (11:15 a.m. ET). The chat will be webcast live on the company's website and will include one-on-one meetings with investors on the same day. ICU Medical is recognized for its infusion systems and critical care products used globally in various healthcare settings.

ICU Medical, a leader in innovative medical products, announced its participation in a fireside chat at the Raymond James 43rd Annual Institutional Investors Conference. This event is scheduled for March 8, 2022, at 11:15 a.m. PT (2:15 p.m. ET). ICU Medical focuses on infusion systems and critical care products, serving hospitals and home care settings globally. The company aims to provide quality and innovation to its clinical customers. For more details, visit icumed.com.

ICU Medical, Inc. (Nasdaq:ICUI) reported fourth quarter 2021 revenue of $340.5 million, up from $320.5 million the previous year. GAAP gross profit rose to $127.5 million with a stable gross margin of 37%. The company posted a GAAP net income of $19.9 million ($0.91 per diluted share), down from $26.1 million ($1.21 per diluted share) year-over-year. Adjusted diluted EPS improved to $1.82 from $1.77. Looking ahead, ICU Medical expects adjusted EBITDA for fiscal 2022 between $450 million and $500 million, with adjusted diluted EPS ranging from $9.00 to $10.50.

ICU Medical (Nasdaq:ICUI) announced the schedule for its fourth quarter 2021 earnings release and conference call. The company will publish its results on February 24, 2022, at approximately 4:00 p.m. ET. A conference call will follow at 4:30 p.m. ET, accessible at (855) 327-6837 with conference ID 10017891. The call will also be available via webcast on the company's website. ICU Medical specializes in infusion systems and critical care products and is headquartered in San Clemente, California.